Roche Gets Breakthrough Status for Alzheimer's Test Elecsys
Author: internet - Published 2018-07-19 07:00:00 PM - (344 Reads)Roche has announced that its Elecsys product for diagnosing Alzheimer's disease has been granted an accelerated review by the U.S. Food and Drug Administration, according to Reuters . The agency has designated Elecsys a breakthrough device. The product analyzes the cerebrospinal fluid in adults with cognitive impairment who are being assessed for Alzheimer's or other causes of dementia.